Daniel P. Pap, D.O.
Interventional Pain Management Specialist
Botox®/Dysport®/Myobloc®/Xeomin® are highly purified, naturally occurring proteins that have the ability to very precisely relax muscles that are causing pain and spasm.
Botox®/Dysport®/Myobloc®/Xeomin® block the chemical signal from the nerve endings that produce muscle contraction and muscle spasm.
Botulinum Toxin is administered as an injection into the muscle.
Botulinum Toxin has been used to treat more than one million patients worldwide. No formal, long-term clinical evaluations have been conducted, but it’s safety in long-term use has been well established.
Most insurance companies including Medicare and Medicaid cover Botox®/Dysport®/Myobloc®/Xeomin® for medically necessary reasons. Pre-authorization is needed which can commonly take up to eight weeks. Insurance may not pay for treatment of certain off-label diagnoses not considered medically necessary.
Botox® was approved by the U.S. Food and Drug Administration in 1989 for the treatment of strabismus (lazy eye) and blepharospasm (uncontrolled eye blinking).
Since that time it has also been approved for cervical dystonia (torticollis), facial wrinkles, migraine, excessive sweating, spasticity, and bladder spasms.
Myobloc® was approved for cervical dystonia only in 2000.
Dysport® was approved in 2009 for cervical dystonia and facial wrinkles.
Xeomin® was approved in 2010 for cervical dystonia and blepharospasm.
Interventional Pain Management Specialist
Interventional Pain Management Specialist
“8 weeks after bad rotator cuff surgery and I am doing well thank you for the great service“
Patrick
Patient
